UnitedHealth Group Incorporated (UNH) trades at $402.94 on $361.04B of equity value, with a trailing P/E of 22.85. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.
Stocklytics score rationale: value 58, quality 32, growth 35.
AI Score 75. UnitedHealth Group has a strong market capitalization of $363 billion and a stable beta of 0.615, indicating lower volatility. However, its current ratio of 0.739 suggests potential liquidity concerns, and a price-to-earnings ratio of 23.1 indicates it may be overvalued relative to earnings growth, which is negative at -2.58%
Summary
UnitedHealth Group Incorporated operates in Healthcare, within the Medical - Healthcare Plans industry. The company pays a dividend with a yield of 2.3%.
Valuation
The shares trade at a price-to-earnings ratio of 22.9 and a price-to-book ratio of 3.5. These figures provide the available valuation context.
Quality
Net margin is 3.5%, indicating the company retains a portion of revenue after expenses. Additional balance-sheet, cash-flow, and return metrics are not provided.
Growth
No revenue, earnings, estimate, or price-trend growth data is provided. Growth cannot be assessed from the available facts.
Risks
The available data does not include debt, cash flow, earnings estimates, or price performance. The Medical - Healthcare Plans industry may also be sensitive to factors not detailed in the facts.